Join to View Full Profile
5323 Harry Hines BlvdDallas, TX 75390
Phone+1 214-645-4673
Fax+1 214-645-2610
Dr. Courtney is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Kevin Courtney is a medical oncologist in Dallas, TX with University of Texas Southwestern Medical Center and the UT Southwestern Harold C. Simmons Comprehensive Cancer Center. He received his MD and his PhD in Molecular Cancer Biology from Duke University School of Medicine. He specializes in genitourinary oncology.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2005 - 2008
University of California (San Francisco)Residency, Internal Medicine, 2002 - 2005
Duke University School of MedicineClass of 2002
Certifications & Licensure
TX State Medical License 2012 - 2027
MA State Medical License 2005 - 2012
CA State Medical License 2004 - 2005
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Publications & Presentations
PubMed
- Clinical Outcomes of Patients With Metastatic Prostate Cancer With Microsatellite Instability Treated With Pembrolizumab.Nicholas Lambert, Casey Moore, Julia Klavon, Waddah Arafat, Jue Wang
Clinical Genitourinary Cancer. 2025-10-01 - Stereotactic Radiation Therapy for the Treatment of Glandular Metastases From Renal Cell Carcinoma.Mihailo Miljanic, Tidie Song, Alana Christie, Allen Yen, Young Suk Kwon
Advances in Radiation Oncology. 2025-09-01 - COSMIC-021 Phase Ib Study of Cabozantinib Plus Atezolizumab: Results from the Locally Advanced or Metastatic Urothelial Carcinoma Cohorts.Sumanta K Pal, Yohann Loriot, Andrea Necchi, Parminder Singh, Daniel Castellano
Journal of Clinical Oncology. 2025-05-10
Journal Articles
- Blocking Monocytic Myeloid-Derived Suppressor Cell Function via Anti-DC-HIL/GPNMB Antibody Restores the in Vitro Integrity of T-cells from Cancer PatientsKevin Courtney, Yull Arriaga, Barbara Haley, John C Mansour, Ponciano D Cruz, David Harker, Farshid Araghizadeh, Clinical Cancer Research
Press Mentions
UTSW’s Simmons Cancer Center Awarded More Than $11.5 Million in CPRIT FundingSeptember 6th, 2024- Children’s Research Institute at UT Southwestern Scientists Discover Kidney Cancers Rely on Mitochondrial Metabolism to MetastasizeAugust 14th, 2024
Findings Establish PT2385 as a Highly Specific HIF-2 Inhibitor for Patients with Clear Cell RCCFebruary 27th, 2020- Join now to see all
Grant Support
- North American Star ConsortiumUNIVERSITY HEALTH NETWORK2014–2026
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
